Precidian ETFs Trust - GSK plc ADRhedged(GSKH)

upturn advisory logo
EXPLORE ADVISORIES AND THEIR HISTORY
QUALITY SIGNAL RECENCY
1-STAR RATING
Consider higher Upturn Star rating
BUY for 6 days
PROFIT SINCE LAST BUY
-4.45% ▼
LAST CLOSE
$69.41
11/20/2026
(24-hour delay)

Advisory History & Simulated Performance *

*as per simulation (see disclosures)
  • ALL
  • 1Y
  • 1M
  • 1W
  • BUY Advisory
  • SELL Advisory (Profit)
  • SELL Advisory (Loss)
  • Profit
  • Loss
  • PASS (Skip)
Upturn Stock price based on last close iconStock price based on last close
Simulated performance—not actual client returns. Excludes advisory subscription fees, trading commissions, and taxes, which would reduce returns. Results depend on calculation assumptions and do not guarantee future outcomes. See Disclosures for full methodology, assumptions, and limitations.

Advisory Performance History (Simulated)Advisory Performance History info

Simulated performance—not actual client returns. Excludes advisory subscription fees, trading commissions, and taxes, which would reduce returns. Results depend on calculation assumptions and do not guarantee future outcomes. See Disclosures for full methodology, assumptions, and limitations.

Upturn Advisory & Investor View for GSKH

11/20/2026: GSKH (1-star) has a low Upturn Star Rating. Not recommended to BUY.

Precidian ETFs Trust - GSK plc ADRhedged (GSKH) provides targeted exposure to the equity performance of GSK plc while neutralizing currency fluctuations between local currencies and the U.S. dollar using derivative overlays. Its main strengths include a low expense ratio of 0.19% and precise currency risk management for US holders. The primary use case is tactical, single-stock international allocation within the healthcare sector. Key risks involve high single-stock concentration and modest trading liquidity. It best suits tactical investors seeking focused pharmaceutical exposure while keeping a close eye on execution spreads and underlying corporate developments.

How to Read the Upturn Advisory

The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.

ETF holdings, costs, diversification, valuation, risks, and market conditions provide supporting context about the fund.

Investor Fit

Investor styleFitWhy
Growth investorWeak fitGSK is a mature pharmaceutical firm rather than a high-growth technology or biotech disruptor.
Momentum investorStrong fit while signal remains positiveTechnical trend-following strategies can utilize GSKH when the underlying pharmaceutical stock shows sustained upward momentum.
Value investorStrong fitThe underlying asset trades at sensible valuation multiples typical of established global pharmaceutical leaders.
Dividend/Income investorStrong fitThe fund provides exposure to GSK's stable dividend-paying profile adjusted for US holders.
Low-risk investorMixed fitWhile currency-hedged, the fund remains heavily concentrated in a single corporate equity, carrying single-stock risk.

Investor Profile

Ideal Investor Profile

Tactical investors or retail traders looking for concentrated exposure to GSK plc while specifically avoiding British pound/USD exchange rate exposure.

Suitability

Best suited for tactical allocations or focused satellite positions rather than core passive index-following portfolios.

Risk Profile

Risk factorLevelWhy it matters
VolatilityMediumAlthough currency fluctuations are hedged, equity price swings inherent to a single pharmaceutical stock still affect returns.
Market riskMedium / high Broad equity market corrections and healthcare sector pressures can pull down the fund's value.
ConcentrationHighThe portfolio is essentially tied to a single underlying company (GSK plc), lacking stock diversification.
Tracking/expenseLowA low expense ratio of 0.19% and effective swap mechanisms keep tracking error manageable.
LiquidityMedium / highLow assets under management and light daily trading volumes can result in wider execution spreads.
Business/sector qualityMediumGSK is a stable global pharma enterprise, but faces ongoing patent cliffs, litigation, and drug pipeline execution risks.

Sector & Industry Intelligence

This fund is not assigned to one sector.

Risk Analysis

Volatility

Historical volatility is tied closely to the equity price fluctuations of GSK plc, moderated by the elimination of currency swings via hedging instruments.

Market Risk

Carries high single-stock concentration risk and sector-specific vulnerabilities tied to the global pharmaceutical industry.

What the ETF Owns

Exposure TypeExposureWeight (%)Retail Investor Read
Single stockGSK plc ADR (GSK)96.07Provides direct economic exposure to the core pharmaceutical business operations of GSK plc.
Cash/collateralUSD Cash and Equivalents3.57Holds liquidity buffers to support daily operations and derivative collateral obligations.
DerivativesOther Assets Less Liabilities / Currency Hedging Contracts0.36Accounts for minor net assets and currency swap adjustments used to hedge exchange rate exposure.

Price Behavior

Downtrend
PRICE PATH

Downtrend

The stock has experienced a sustained decline in price over recent periods.

Smooth
PRICE STABILITY

Smooth

The stock has moved along a generally orderly path with only modest fluctuations.

Analysis of Past Performance

Type ETF
Historic Profit -11.76%
Avg. Invested days 31
Today’s Advisory Consider higher Upturn Star rating
Upturn Advisory Rating upturn star rating icon
Upturn Advisory Performance Upturn Advisory Performance icon 1.0
ETF Returns Performance Upturn Returns Performance icon 1.0
Upturn Profits based on simulation icon Profits based on simulation
Upturn last close icon Last Close 11/20/2026
Form CRS provides a relationship summary of our automated advisory services, flat subscription fees, and conflicts of interest. Form ADV Part 2A brochure contains complete details on services, billing, and disclosures. If any summary differs from our current regulatory filings, the filed Form ADV controls.